Healx, an AI-powered, clinical-stage biotech company dedicated to rare diseases, today announced that the first ...
An artificial intelligence (AI)-based model accurately classified pediatric sarcomas using digital pathology images alone, according to results presented at the American Association for Cancer ...
CHICAGO and FORT WORTH, Texas, July 17, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on ...
Ladera Ranch residents are concerned about a rise in rare synovial sarcoma cases among children. Parents believe an unknown ...
University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood cancer in 40 years. Associate Professor Fernando Guimaraes, a Principal ...
AYA cancer patients with sarcoma may not know resources, including palliative care, are available, and may resist them when ...
"Do not allow medical professionals to dismiss your concerns," Alison Miller tells PEOPLE Alison Miller A mom of a 2-year-old boy diagnosed with cancer is urging parents to be persistent with doctors ...
In this phase 3 trial, researchers aimed to characterize the clinical characteristics, treatment approaches, and outcomes of patients with metastatic non-rhabdomyosarcoma soft tissue sarcoma and to ...
Kaposi's sarcoma (KS) is a low-grade vascular neoplasm mediated by the human herpesvirus-8. Only 1 clinical subtype, the endemic/African subtype, commonly affects the pediatric population. Although ...
Healx begins patient dosing in phase 1/2 trial to evaluate the effect of HLX-4310 on metastatic recurrence and progression in sarcomas with a focus on osteosarcoma: Cambridge, UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results